Your browser doesn't support javascript.
loading
A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.
Hartley, Anna; Burger, Luisa; Wincek, Cornelia L; Dons, Lieke; Li, Tracy; Grewenig, Annabel; Tasgin, Toros; Urban, Manuela; Roig-Merino, Alicia; Ghazvini, Mehrnaz; Harbottle, Richard P.
Afiliación
  • Hartley A; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Burger L; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
  • Wincek CL; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Dons L; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
  • Li T; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Grewenig A; Erasmus MC iPS Core Facility, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
  • Tasgin T; Erasmus MC iPS Core Facility, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands.
  • Urban M; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Roig-Merino A; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
  • Ghazvini M; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
  • Harbottle RP; DNA Vector Laboratory, German Cancer Research Center, 69120 Heidelberg, Germany.
Genes (Basel) ; 15(5)2024 04 30.
Article en En | MEDLINE | ID: mdl-38790204
ABSTRACT
Induced pluripotent stem cells (iPSCs) are a powerful tool for biomedical research, but their production presents challenges and safety concerns. Yamanaka and Takahashi revolutionised the field by demonstrating that somatic cells could be reprogrammed into pluripotent cells by overexpressing four key factors for a sufficient time. iPSCs are typically generated using viruses or virus-based methods, which have drawbacks such as vector persistence, risk of insertional mutagenesis, and oncogenesis. The application of less harmful nonviral vectors is limited as conventional plasmids cannot deliver the levels or duration of the factors necessary from a single transfection. Hence, plasmids that are most often used for reprogramming employ the potentially oncogenic Epstein-Barr nuclear antigen 1 (EBNA-1) system to ensure adequate levels and persistence of expression. In this study, we explored the use of nonviral SMAR DNA vectors to reprogram human fibroblasts into iPSCs. We show for the first time that iPSCs can be generated using nonviral plasmids without the use of EBNA-1 and that these DNA vectors can provide sufficient expression to induce pluripotency. We describe an optimised reprogramming protocol using these vectors that can produce high-quality iPSCs with comparable pluripotency and cellular function to those generated with viruses or EBNA-1 vectors.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Plásmidos / Reprogramación Celular / Células Madre Pluripotentes Inducidas / Fibroblastos / Vectores Genéticos Límite: Humans Idioma: En Revista: Genes (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Plásmidos / Reprogramación Celular / Células Madre Pluripotentes Inducidas / Fibroblastos / Vectores Genéticos Límite: Humans Idioma: En Revista: Genes (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Alemania